Exogenous compounds, such as AICAR, bezafibrate, and resveratrol, can stimulate mitochondrial biogenesis via activation of the PPARγ/PGC-1α pathway, and thus have been considered as potential leads for mitochondrial disease treatment [35]. Here, PPARGC1A is linked to mitochondrial disease.